zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials za sistemsko uporabo, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
atriance
sandoz pharmaceuticals d.d. - nelarabin - predkroglomerna limfoma t-celična limfoblastna levkemija - antineoplastična sredstva - nelarabine je indiciran za zdravljenje bolnikov z t-celic acute lymphoblastic levkemijo (t-all) in t-celic lymphoblastic limfom (t-lbl), katerih bolezen ni odgovorila, ali je relapsed po zdravljenju z vsaj dvema kemoterapijo regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.
bosentan sandoz 62,5 mg filmsko obložene tablete
sandoz d.d. - bosentan - filmsko obložena tableta - bosentan 62,5 mg / 1 tableta - bosentan
biphozyl raztopina za hemodializo/hemofiltracijo
gambro lundia ab - kalijev klorid; magnezijev klorid heksahidrat; natrijev hidrogenfosfat dihidrat; natrijev hidrogenkarbonat; natrijev klorid; kalijev klorid - raztopina za hemodializo/hemofiltracijo - kalijev klorid 0,314 g / 1000 ml magnezijev klorid heksahidrat3,05 g / 1000 ml natrijev hidrogenfosfat dihidrat0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; magnezijev klorid heksahidrat 3,05 g / 1000 ml natrijev hidrogenfosfat dihidrat0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev hidrogenfosfat dihidrat 0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev hidrogenkarbonat 2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev klorid 7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; kalijev klorid 0,314 g / 1000 ml - zdravila za filtracijo krvi
bosentan sandoz 125 mg filmsko obložene tablete
sandoz d.d. - bosentan - filmsko obložena tableta - bosentan 125 mg / 1 tableta - bosentan
hycamtin
sandoz pharmaceuticals d.d. - topotekan - ovarian neoplasms; uterine cervical neoplasms; small cell lung carcinoma - antineoplastična sredstva - hycamtin kapsule so navedene kot monoterapijo za zdravljenje odraslih bolnikov s relapsa mala pljučnega raka (sclc) za katere ponovno obdelavo z začetno režim ne velja za ustrezno. topotecan je indiciran za zdravljenje bolnikov z metastatskim karcinom iz jajčnikov po okvari prvo vrstico ali zaporedne terapije. hycamtin kapsule so navedene kot monoterapijo za zdravljenje odraslih bolnikov s relapsa mala pljučnega raka (sclc) za katere ponovno obdelavo z začetno režim ne velja za ustrezno.
aclasta
sandoz pharmaceuticals d.d. - zoledronska kislina - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - zdravila za zdravljenje bolezni kosti - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. zdravljenje osteoporoze, povezane z dolgoročno sistemsko glukokortikoidnih terapije v post-menopavzi in pri moških povečano tveganje za zlom. zdravljenje paget je bolezen kosti.
bimatoprost sandoz 0,3 mg/ml kapljice za oko, raztopina
sandoz d.d. - bimatoprost - kapljice za oko, raztopina - bimatoprost 0,3 mg / 1 ml - bimatoprost
kalcijev folinat sandoz 10 mg/ml raztopina za injiciranje/infundiranje
sandoz gmbh - folinska kislina - raztopina za injiciranje/infundiranje - folinska kislina 10 mg / 1 ml - kalcijev folinat